| Product Code: ETC13129688 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Non-24-Hour Sleep-Wake Disorder Drug Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Non-24-Hour Sleep-Wake Disorder Drug Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market - Industry Life Cycle |
3.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market - Porter's Five Forces |
3.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.9 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.11 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Non-24-Hour Sleep-Wake Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Non-24-Hour Sleep-Wake Disorder Drug Market Trends |
6 North America Non-24-Hour Sleep-Wake Disorder Drug Market, 2021 - 2031 |
6.1 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Circadian Rhythm Sleep Disorder, 2021 - 2031 |
6.1.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Hypernychthemeral Syndrome, 2021 - 2031 |
6.1.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Shift Work Disorder, 2021 - 2031 |
6.1.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Jet Lag and Others, 2021 - 2031 |
6.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Therapeutic Devices, 2021 - 2031 |
6.2.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.2.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Nonbenzodiazepines, 2021 - 2031 |
6.3.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Benzodiazepines, 2021 - 2031 |
6.3.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.4.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Home Care Settings, 2021 - 2031 |
6.5.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.5.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Wellness Centers and Spa, 2021 - 2031 |
6.5.6 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.6.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drug Stores, 2021 - 2031 |
6.6.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.6.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Non-24-Hour Sleep-Wake Disorder Drug Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.1 United States (US) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.2 Canada Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.2.3 Rest of North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Indication, 2021 - 2031 |
7.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
7.3.1 United States (US) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.3.2 Canada Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.3.3 Rest of North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4.1 United States (US) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4.2 Canada Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4.3 Rest of North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 United States (US) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 Canada Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Rest of North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.6.1 United States (US) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.6.2 Canada Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.6.3 Rest of North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.7 North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.1 United States (US) Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.2 Canada Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.3 Rest of North America Non-24-Hour Sleep-Wake Disorder Drug Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Non-24-Hour Sleep-Wake Disorder Drug Market Key Performance Indicators |
9 North America Non-24-Hour Sleep-Wake Disorder Drug Market - Export/Import By Countries Assessment |
10 North America Non-24-Hour Sleep-Wake Disorder Drug Market - Opportunity Assessment |
10.1 North America Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
10.3 North America Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
10.4 North America Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10.5 North America Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 North America Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
10.7 North America Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Non-24-Hour Sleep-Wake Disorder Drug Market - Competitive Landscape |
11.1 North America Non-24-Hour Sleep-Wake Disorder Drug Market Revenue Share, By Companies, 2022 |
11.2 North America Non-24-Hour Sleep-Wake Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here